Welcome to Pivotal Scientific
Welcome to Pivotal Scientific Ltd (PSL), the only biotechnology consultancy in the world that works specifically with research reagent manufacturers:
- We help enterprises located worldwide grow their brand and sales by supporting them at all stages of the business life cycle.
- We are a “one-stop shop” offering a portfolio of services that biotech companies can pick and choose to suit their growth strategies.
See What Our Clients Say About Us
PSL was appointed 3 years ago to provide guidance in building a sustainable distributor network for LSBio. This distributor network has delivered great growth during Tim’s consultancy and he now remains available for general B2B advice on the Antibody market.
‘Pivotal Scientific has been instrumental in growing Innova Biosciences into a business with distributors covering Asia Pacific, Europe and North America. Their knowledge base and understanding of the various cultures were key in making Innova Biosciences a successful company operating on an international basis.’
DB Biotech, Ltd, Popradska 80, Kosice, Slovakia has been involved in collaboration with Pivotal Scientific Limited , represented by Mr Tim Bernard since 2008, in order to establish the OEM and distributor relationship with key players in development, production and sales of monospecific antibodies in the world market. This collaboration brought a lot of new opportunities with new projects and business related applications of new quality of monospecific rabbit antibodies, developed and produced by DB biotech for research and clinical diagnostics applications.
Tim and the PSL team have worked with AbCore since our inception in 2011. We have used the full suite of PSL services including Business and Financial Planning and their individual Sales & Marketing services. Theclarity they have brought to our business, together with our rapid growth in sales and employees means we are truly grateful for their personal support. We have introduced PSL to other biotech firms in San Diego and will continue to do so.”